3DMed's current stock price is clearly unreasonable. Its financial situation and the prospects of core product indicate that its survival issues are difficult to guarantee.Bubble will eventually burst
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.